| Antisense oligonucleotides as a potential treatment for brain deficits observed in myotonic dystrophy type 1 S Ait Benichou, D Jauvin, T de Serres-Bérard, M Pierre, KK Ling, ... Gene Therapy 29 (12), 698-709, 2022 | 38 | 2022 |
| Deciphering DSC2 arrhythmogenic cardiomyopathy electrical instability: From ion channels to ECG and tailored drug therapy A Moreau, J Reisqs, H Delanoe‐Ayari, M Pierre, A Janin, A Deliniere, ... Clinical and translational medicine 11 (3), e319, 2021 | 22 | 2021 |
| Deciphering the mechanisms underlying brain alterations and cognitive impairment in congenital myotonic dystrophy T De Serres-Bérard, M Pierre, M Chahine, J Puymirat Neurobiology of Disease 160, 105532, 2021 | 20 | 2021 |
| NaV1.5 knockout in iPSCs: a novel approach to study NaV1.5 variants in a human cardiomyocyte environment M Pierre, M Djemai, H Poulin, M Chahine Scientific reports 11 (1), 17168, 2021 | 17 | 2021 |
| Combining NGN2 programming and dopaminergic patterning for a rapid and efficient generation of hiPSC-derived midbrain neurons R Sheta, M Teixeira, W Idi, M Pierre, A de Rus Jacquet, V Emond, ... Scientific Reports 12 (1), 17176, 2022 | 15 | 2022 |
| Generation of four myotonic dystrophy type 1 patient iPSC lines (CBRCULi002-A, CBRCULi003-A, CBRCULi004-A, CBRCULi005-A) and a control (CBRCULi001-A) derived from … D Jauvin, M Pierre, M Boutjdir, J Puymirat, M Chahine Stem Cell Research 67, 103037, 2023 | 9 | 2023 |
| Biophysical properties of NaV1.5 channels from atrial-like and ventricular-like cardiomyocytes derived from human induced pluripotent stem cells CA Chapotte-Baldacci, M Pierre, M Djemai, V Pouliot, M Chahine Scientific Reports 13 (1), 20685, 2023 | 5 | 2023 |
| Cardiac involvement in patient-specific induced pluripotent stem cells of myotonic dystrophy type 1: unveiling the impact of voltage-gated sodium channels M Pierre, M Djemai, CA Chapotte-Baldacci, V Pouliot, J Puymirat, ... Frontiers in Physiology 14, 2023 | 4 | 2023 |
| Lymphoblastoid cell lines derived from iPSCs of a myotonic dystrophy type 1 patient carrying 700 CTG repeats (CBRCULi007-A) and a control (CBRCULi006-A) M Chahine, D Jauvin, M Pierre, J Puymirat, M Boutjdir Stem Cell Research, 103148, 2023 | 2 | 2023 |
| Characterization of atrial fibrillation linked mutations using the Nav1. 5 knock-out of atrial cardiomyocytes derived from iPSCs M Pierre, CA Chapotte-Baldacci, M Djemai, M Chahine Biophysical Journal 122 (3), 100a, 2023 | | 2023 |
| Biophysical properties of Nav1. 5 channel in ventricular-like and atrial-like chamber cardiomyocytes derived from human induced pluripotent stem cells CA Chapotte-Baldacci, M Pierre, M Djemaï, M Chahine Biophysical Journal 122 (3), 99a, 2023 | | 2023 |
| Chapitre 3: Développement d’une thérapie pour les manifestations cérébrales de la DM1 SA Benichou, D Jauvin, T De Serres-Bérard, M Pierre, KK Ling, ... Développement d'une thérapie génique basée sur l’utilisation d …, 2023 | | 2023 |
| Nav1. 5 knockout in iPSCs: a novel approach to study Nav1. 5 variants in a human cardiomyocyte environment M Pierre, M Djemai, H Poulin, M Chahine Biophysical Journal 121 (3), 94a, 2022 | | 2022 |
Mohamed ChahineFull professor, laval UniversityOverená e-mailová adresa na: phc.ulaval.ca